Lv1
40 积分 2023-01-29 加入
Atopic dermatitis
2天前
已完结
Atopic dermatitis
2天前
已完结
MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study
2年前
已完结
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
2年前
已完结
皖公网安备34019202002308
